Surgical and radiosurgical treatment strategies for Cushing's disease

被引:12
作者
Bunevicius, Adomas [1 ]
Laws, Edward R. [2 ]
Vance, Mary Lee [1 ,3 ]
Iuliano, Sherry [2 ]
Sheehan, Jason [1 ,4 ]
机构
[1] Univ Virginia, Dept Neurosurg, Charlottesville, VA 22903 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA
[3] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA USA
[4] Univ Virginia Hlth Syst, Charlottesville, VA 22903 USA
关键词
Cushing's disease; Pituitary adenoma; Surgery; Radiosurgery; Gamma knife; LINEAR-ACCELERATOR RADIOSURGERY; GAMMA-KNIFE RADIOSURGERY; TRANSSPHENOIDAL SURGERY; STEREOTACTIC RADIOSURGERY; PITUITARY-ADENOMAS; DURAL INVASION; MANAGEMENT; REMISSION; OUTCOMES; EXPERIENCE;
D O I
10.1007/s11060-019-03325-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Cushing's disease (CD) is rare disorder that should be adequately managed to optimize long-term prognosis. Treatment of CD is multidisciplinary and often includes surgical resection, adjuvant stereotactic radiosurgery (SRS), and medical treatment. Here we review surgical and radiosurgical treatment strategies for ACTH producing pituitary adenomas. Methods A comprehensive literature review was carried out to review remission and recurrence rates, and complications of surgical and SRS treatments of ACTH producing pituitary adenomas. Results Surgical resection plays a central role in the management of ACTH secreting pituitary adenomas and usually allows rapid endocrine remission that ranges from 69 to 90%. The most common complications after resection include some degree of new hypopituitarism, diabetes insipidus and CSF leak. Devastating complications, such as injury of vascular and neural structures, are very rare. Surgeon experience and adequate pre-operative imaging are important for safe and successful surgery. Endocrine recurrence rates after resection range from 9 to 30%. SRS is often employed for incompletely resected adenomas. Endocrine remission after SRS ranges from 35 to 72%. The most common complication of SRS is new anterior pituitary gland deficiency. Recurrence rates after GKRS range from 18 to 24%. Conclusions Transsphenoidal resection of ACTH producing pituitary adenoma is a safe and highly effective procedure for CD in experienced hands. Radiosurgery is more frequently used as treatment of residual and recurrent adenoma and persistent CD. Long-term endocrine and imaging follow-up is important as delayed recurrences and hypopituitarism are not infrequent.
引用
收藏
页码:403 / 413
页数:11
相关论文
共 64 条
[1]   Management of recurrent and refractory Cushing disease [J].
Aghi, Manish K. .
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (10) :560-568
[2]   Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease [J].
Asuzu, David ;
Chatain, Gregoire P. ;
Hayes, Christina ;
Benzo, Sarah ;
McGlotten, Raven ;
Keil, Meg ;
Beri, Andrea ;
Sharma, Susmeeta T. ;
Nieman, Lynnette ;
Lodish, Maya ;
Stratakis, Constantine ;
Lonser, Russell R. ;
Oldfield, Edward H. ;
Chittiboina, Prashant .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (07) :2179-2187
[3]   Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: Mortality, morbidity, and the effects of hospital and surgeon volume [J].
Barker, FG ;
Klibanski, A ;
Swearingen, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10) :4709-4719
[4]   Modern imaging of pituitary adenomas [J].
Bashari, Waiel A. ;
Senanayake, Russell ;
Fernandez-Pombo, Antia ;
Gillett, Daniel ;
Koulouri, Olympia ;
Powlson, Andrew S. ;
Matys, Tomasz ;
Scoffings, Daniel ;
Cheow, Heok ;
Mendichovszky, Iosif ;
Gurnell, Mark .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 33 (02)
[5]   Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients <65 years old in the United States [J].
Broder, Michael S. ;
Neary, Maureen P. ;
Chang, Eunice ;
Cherepanov, Dasha ;
Ludlam, William H. .
PITUITARY, 2015, 18 (03) :283-289
[6]   Improvement but No Normalization of Quality of Life and Cognitive Functioning After Treatment of Cushing Syndrome [J].
Broersen, Leonie H. A. ;
Andela, Cornelie D. ;
Dekkers, Olaf M. ;
Pereira, Alberto M. ;
Biermasz, Nienke R. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (11) :5322-5334
[7]   Long-Term Results of Stereotactic Radiosurgery in Secretory Pituitary Adenomas [J].
Castinetti, Frederic ;
Nagai, Mariko ;
Morange, Isabelle ;
Dufour, Henry ;
Caron, Philippe ;
Chanson, Philippe ;
Cortet-Rudelli, Christine ;
Kuhn, Jean-Marc ;
Conte-Devolx, Bernard ;
Regis, Jean ;
Brue, Thierry .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (09) :3400-3407
[8]   Occult Cushing's syndrome in type-2 diabetes [J].
Catargi, B ;
Rigalleau, V ;
Poussin, A ;
Ronci-Chaix, N ;
Bex, V ;
Vergnot, V ;
Gin, H ;
Roger, P ;
Tabarin, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12) :5808-5813
[9]   Complications of transsphenoidal surgery: Results of a national survey, review of the literature, and personal experience [J].
Ciric, I ;
Ragin, A ;
Baumgartner, C ;
Pierce, D .
NEUROSURGERY, 1997, 40 (02) :225-236
[10]   Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study [J].
Clayton, Richard N. ;
Jones, Peter W. ;
Reulen, Raoul C. ;
Stewart, Paul M. ;
Hassan-Smith, Zaki K. ;
Ntali, Georgia ;
Karavitaki, Niki ;
Dekkers, Olaf M. ;
Pereira, Alberto M. ;
Bolland, Mark ;
Holdaway, Ian ;
Lindholm, Jorgen .
LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (07) :569-576